To include your compound in the COVID-19 Resource Center, submit it here.

Cell Genesys, Japan Tobacco deal

CEGE and Japan Tobacco terminated their licensing deal for CEGE's GVAX

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE